|
COX11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.236750E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.498290E-03 |
| Normal-vs-Stage2 |
3.695600E-02 |
| Normal-vs-Stage3 |
4.340400E-03 |
| Normal-vs-Stage4 |
7.853800E-01 |
| Stage1-vs-Stage2 |
6.853200E-01 |
| Stage1-vs-Stage3 |
4.332600E-01 |
| Stage1-vs-Stage4 |
1.631830E-01 |
| Stage2-vs-Stage3 |
7.942600E-01 |
| Stage2-vs-Stage4 |
1.592800E-01 |
| Stage3-vs-Stage4 |
8.111900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.044400E-04 |
| Normal-vs-AfricanAmerican |
1.014190E-01 |
| Normal-vs-Asian |
5.503400E-01 |
| Caucasian-vs-AfricanAmerican |
4.237200E-01 |
| Caucasian-vs-Asian |
9.033200E-01 |
| AfricanAmerican-vs-Asian |
8.863800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.76790000003557E-06 |
| Normal-vs-Female |
3.558000E-01 |
| Male-vs-Female |
4.980400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.938600E-03 |
| Normal-vs-Extreme_Weight |
1.832710E-04 |
| Normal-vs-Obese |
1.949550E-02 |
| Normal-vs-Extreme_Obese |
9.578800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.294000E-01 |
| Normal_Weight-vs-Obese |
5.857600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.393600E-01 |
| Extreme_Weight-vs-Obese |
4.397200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.183000E-01 |
| Obese-vs-Extreme_Obese |
5.444200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.680200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.694500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.37690000000068E-05 |
| Normal-vs-Age(81-100Yrs) |
5.024900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.920600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.907800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.313800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.610100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.952300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.949200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.343400E-03 |
| Normal-VS-Type2 PRCC |
3.255400E-03 |
| Normal-VS-KIRP CIMP |
9.556800E-01 |
| Normal-VS-Unclassified PRCC |
4.030000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.771600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.715800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.428400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.224000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.226200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.663400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.435800E-04 |
| Normal-vs-N1 |
1.560410E-01 |
| Normal-vs-N2 |
7.633000E-01 |
| N0-vs-N1 |
4.016400E-01 |
| N0-vs-N2 |
4.577600E-01 |
| N1-vs-N2 |
3.174800E-01 |
|
|
